Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Experimental and Applied Biomedical Research (EABR)
AHEAD OF PRINT
Open Access
Role of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib in the Management of Neuroblastoma
Yasemin Benderli Cihan
Yasemin Benderli Cihan
| Jan 10, 2019
Experimental and Applied Biomedical Research (EABR)
AHEAD OF PRINT
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Jan 10, 2019
Page range:
-
Received:
Dec 04, 2018
Accepted:
Jul 27, 2018
DOI:
https://doi.org/10.2478/sjecr-2018-0066
Keywords
neuroblastoma
,
ALK inhibitors
,
therapy
,
children
© 2019 Yasemin Benderli Cihan, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Yasemin Benderli Cihan
Kayseri Education and Research Hospital, Department of Radiation Oncology,
Kayseri, Turkey